What are the hottest articles on the interactive investor website right now? These are the stories, tips and research investors have been most interested in this past week.
1) Ian Cowie: sickly returns during pandemic for healthcare trusts
Our columnist is continuing to back health to deliver long-term wealth, despite performance disappointing during Covid.
2) Battle of the $200bn drug giants: there’s only one winner
Both these companies have delivered solid returns for shareholders, but our overseas investing expert believes there is a clear choice about which one to buy.
3) Dogs of the Footsie: 10 highest-yielding shares revealed for 2022
We name the 10 shares in the 2022 line-up. Will the dogs outperform the wider market this year?
4) Jeff Prestridge why ISA investors need to forget the use it or lose it message
One day, the ISA tap will be turned off on the grounds that it is a too-generous, middle-class tax perk, predicts our columnist. But before then, he suggests how investors might approach the wrapper in the current climate.
5) Dividend dilemma: the trade-off between yield and growth
Kepler examines whether it is best to maximise income today, or wait for potentially higher dividends in the future.
- Watch our share, fund and trust tips, plus outlook videos for 2022
- Take control of your retirement planning with our award-winning, low-cost Self-Invested Personal Pension (SIPP)
- Check out our award-winning stocks and shares ISA
6) Bank sector results preview: the profits league table
UK banks begin reporting annual results next week. Here’s how much the analysts expect each of the Big Five made in 2021.
7) The 12 most-consistent funds over the past three years
However, half the funds have produced a negative return over the past six months due to being negatively impacted by the market rotation.
8) Is Lloyds the pick of the UK banking bunch?
As the Big Five get ready to report their annual results, Richard Hunter examines the preferred plays in the sector.
9) 10 shares to give you a £10,000 annual income in 2022
There are lots of big dividend payers out there, but our head of equity strategy wants to strike a balance between glamour yields and reliability this year.
10) Insider: FTSE 100 buying and a top small-cap
One is a FTSE 100 consumer goods giant, the other is a top-performing green economy small-cap. Their results have led to buying among directors.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.